SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MskiHntr who wrote (713)10/12/1998 10:41:00 AM
From: MskiHntr  Read Replies (1) of 756
 
Good morning, all. Found this on the DJ News Wire:

Symbol(s) IVX & Date
Use Page Up, Page Down, +, -, or press Ù
--------------------------------------------------------------------------------
10/12 10:20A (DJ) =Prices Seen Driving Higher Profits At Most Generic-Drug Cos

Earnings at Ivax Corp. (IVX) are also on the upswing, industry observers
said. The third quarter will mark the first time in several years that the
Miami company has posted sequential quarters of profitability, said HKS & Co.
analyst Hemant Shah.
"There's no question that Ivax is turning around,"he said.
The company, which recently underwent a major restructuring, is back to
focusing on its core businesses, a move that is shaving costs and positioning
it to garner the highest possible margins, Shah said.
Analysts surveyed by First Call expect Ivax will earn 5 cents a share in the
quarter, compared with a loss from continuing operations of 65 cents a year
earlier. The year-ago figure includes a 4-cent restructuring charge.

Best, Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext